GoyalMOspelJMHillMD. Will there be a rapid change towards an EVT-only paradigm?Inter Neuroradiol2021; 27: 744–745.
2.
GaneshAAl-AjlanFSSabiqF, et al.Infarct in a New territory after treatment administration in the ESCAPE randomized controlled trial (endovascular treatment for small core and anterior circulation proximal occlusion With emphasis on minimizing CT to recanalization times). Stroke2016; 47: 2993–2998.
3.
ZiWQiuZLiF, et al.Effect of endovascular treatment alone vs intravenous alteplase Plus endovascular treatment on functional independence in patients With acute ischemic stroke: the DEVT randomized clinical trial. JAMA2021; 325: 234–243.
4.
YangPZhangYZhangL, et al.Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med2020; 382: 1981–1993.
5.
SuzukiKMatsumaruYTakeuchiM, et al.Effect of mechanical thrombectomy without vs With intravenous thrombolysis on functional outcome Among patients With acute ischemic stroke: the SKIP randomized clinical trial. JAMA2021; 325: 244–253.
6.
LeCouffeNEKappelhofMTreurnietKM, et al.A randomized trial of intravenous alteplase before endovascular treatment for stroke. N Engl J Med2021; 385: 1833–1844.
7.
TsivgoulisGTurcGPsychogiosMN, et al.Utility of intravenous alteplase prior to endovascular stroke treatment: a systematic review and meta-analysis of randomized controlled clinical trials. (RO0052/#1077). Eur Stroke J2021; 6: 135. ESOC Annual conference 1-3 September 2021 Virtual.
8.
HillMDGoyalMMenonBK, et al.Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet2020; 395: 878–887.
